Patient Reported Symptom Control With THC or CBD Use

This study compares patients' attitudes regarding marijuana products for medical use and other treatments for cancer-related pain. This study may help researchers gain better understanding of patient's perception on their use of marijuana products in treating cancer-related pain and other common cancer-related symptoms.

Inclusion Criteria: * Patients (inpatient or outpatient) seen by the Palliative Care and Integrative Medicine teams at The University of Texas MD Anderson Cancer Center (Texas) and the Palliative Care team at Banner MD Anderson Cancer Center (Arizona) * Patients must be primary residents of Texas or Arizona * Patients able to speak and read English * Patients are 18 years old and above * Patients should have a cancer diagnosis, cancer-associated pain, and taking strong opioids (morphine, oxycodone, hydrocodone, hydromorphone, oxymorphone, methadone, fentanyl) * Patients who have used in the past 3 months or are using alternative botanical pain management while under prescription opioids Exclusion Criteria: * Patients who are not able to speak or read English * Altered mental status as determined by the interviewer based on the ability to understand the nature of the study and consent process * Patients who have not used medical marijuana and/or CBD products * Patients who do not have cancer * Patients who do not have cancer-associated pain * Patients who are not taking opioids